621 Interim Analysis of a Phase II Study of Talimogene Laherparepvec (T-VEC) Followed by Combination T-VEC + Nivolumab in Non-Melanoma Skin Cancers and Refractory Cutaneous Lymphoma (NCI#10057) Ann W Silk , Gino K In , Nicole R Leboeuf , Diwakar Davar , Sunandana Chandra , George Ansstas , Melissa Burgess , Frederick Lansigan , Theresa Medina , Brad Haverkos , Stephen Williamson , John Hyngstrom , Howard L Kaufman , Anita Giobbie-Hurder , Harita Dharaneeswaran , Diane Del Valle , Kai Nie , Sinem Ozbey , Giorgio Ioannou , Igor De Souza Figueiredo , Ronaldo De Real , Bryan Villagomez , Elena Colicino , Seunghee Kim-Schulze , Kenneth Livak , Catherine J Wu , Helen Chen , Edgar Gonzalez-Kozlova , Sacha Gnjatic , Janice Mehnert Regular and Young Investigator Award Abstracts（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
